Predictive algorithms for molecular design, biomarker discovery and digital optimization of clinical trials are just some of the ways these technologies are already being applied today across research and development. With our scientific strategies increasingly placing prediction at the heart of drug development, the potential of these approaches to advance our mission will be even greater tomorrow.
Our strong in-house capabilities in this field are augmented by strategic collaborations that align with our broader vision, increasing our ability to accelerate the discovery of new drug candidates, advance their timely development into clinical trials, and optimize their use for improved patient outcomes. This approach is delivering already, as evidenced by the recent arrival of an AI-designed drug candidate.
Much remains to discover, but the promise is clear. Harnessing the power of prediction will drive research innovation, optimize clinical trials and enable transformative therapeutic approaches. AI-enabled predictive technologies bring greater precision at every step, from the inception of our programs to the launch of innovative medicines that help patients prevail over serious diseases.